Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05850234 |
| Title | A Study of GC012F, a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Gracell Biopharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Colorado Blood and Cancer Institute | NOT_YET_RECRUITING | Denver | Colorado | 80218 | United States | Details |
| Icahn School of Medicine at Mount Sinai | RECRUITING | New York | New York | 10029 | United States | Details |
| SCRI Tennessee Oncology | NOT_YET_RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| SAMC South Austin Medical Center | NOT_YET_RECRUITING | Austin | Texas | 78745 | United States | Details |